Trial for Retractor Sponge Evaluation in Laparoscopic Colorectal Surgery (SPONGE)

May 29, 2019 updated by: dr. A.B. Smits, St. Antonius Hospital

Randomized Controlled Trial to Evaluate the Effect of a Retractor Sponge in Postoperative Hospital Stay in Laparoscopic Colorectal Surgery in Patients With Malignancy

Laparoscopic surgery of the distal colon and rectum requires surgery with an appropriate field of view. A commonly used technique to create a clear exposure is the steep Trendelenburg position in which the patient is positioned in an angle of 15 to 40 degrees with the head down using the effect of gravity to retract the small intestine. This method is associated with haemostatic changes caused by the cranial shift of abdominal organs and blood. Recently, a cellulose compressed sponge was developed as intraoperative retractor, with the aim to keep the small intestines aside while the patient remains in a horizontal position. The safety of the sponge is secured with CE marking. The retractor sponge ensures a clear surgical field and potentially prevents haemostatic instability by avoiding Trendelenburg position. A pilot study in the St Antonius Hospital Nieuwegein has shown that use of the sponge might be associated with shorter hospital stay.

Study Overview

Status

Unknown

Intervention / Treatment

Detailed Description

Objective: We study the efficacy of the retractor sponge in laparoscopic colorectal surgery to reduce hospital stay in patients operated for a malignancy. Secondary objectives are duration of surgery, blood-loss, use of diuretics as volume therapy (during surgery as wells as during total hospital stay), postoperative hypoxemia and peri- and postoperative complications.

Study design: Randomized controlled trial, nested within a prospective cohort according to the 'cohort multiple randomized controlled trial' (cmRCT) design.

Study population: Patients with colorectal cancer who undergo laparoscopic surgery, and who have given informed consent to be offered experimental interventions within the PICNIC project. Patient who require open surgery or patients with benign colorectal diseases are excluded for this study.

Intervention: Intraoperative use of the retractor sponge versus usual care, i.e. the Trendelenburg position.

Main study parameters/endpoints: The primary endpoint is length of hospital stay. Secondary endpoints are duration of surgery, blood-loss, use of diuretics (during surgery as wells as during total hospital stay), postoperative hypoxemia and peri- and postoperative surgical, pulmonary and cardiac complications.

Nature and extent of the burden and risks associated with participation, benefit and group relatedness: The study will be conducted according to the cohort multiple Randomized Controlled Trial (cmRCT) design. Within the PICNIC cohort, we will identify all patients who are eligible for the experimental intervention (use of the sponge) and who have given informed consent to be invited for future experimental interventions. From this sub cohort, we will randomly select a group of patients to whom we will offer surgery with use of the retractor sponge, which they can accept or decline. Eligible patients from the sub cohort who were not randomly selected will undergo standard treatment, i.e. surgery in Trendelenburg position. We do not expect adverse events in patients in the intervention arm, besides dysfunction of the sponge, after which conversion to standard treatment (Trendelenburg position) needs to take place.

Study Type

Interventional

Enrollment (Anticipated)

188

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

    • Utrecht
      • Nieuwegein, Utrecht, Netherlands, 3430EM
        • Recruiting
        • St. Antonius Hospital
        • Contact:
        • Contact:
        • Principal Investigator:
          • Anke B Smits, MD/PhD
        • Sub-Investigator:
          • Alice M Couwenberg, BSc
        • Sub-Investigator:
          • Johannes PM Burbach, MD
        • Sub-Investigator:
          • Helena M Verkooijen, MD/AssProf
        • Sub-Investigator:
          • Peter G Noordzij, MD/PhD
        • Sub-Investigator:
          • Onne Reerink, MD/PhD
        • Sub-Investigator:
          • Marco van Vulpen, MD/Prof

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 95 years (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion criteria:

  • Participant in the PICNIC project (METC 12-510)
  • Informed consent obtained for being offered experimental interventions within the PICNIC project
  • Informed consent obtained for questionnaires on patient reported outcomes within the PICNIC project
  • Planned for laparoscopic surgery of distal colorectal cancer in St. Antonius Hospital

Exclusion Criteria:

  • Planned for open colorectal surgery
  • Surgery for benign colorectal diseases
  • Emergency colorectal surgery
  • Inadequate understanding of the Dutch language in speech and/or writing

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: TREATMENT
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: NONE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Sponge group
Patients offered surgery with the retractor sponge
Compressed cellulose sponge for use in laparoscopic surgery to retract the intestines from the surgical field.
Other Names:
  • Endoractor, Kawamoto corporation (Osaka, Japan)
No Intervention: Control group
Patients receiving standard care: surgery in Trendelenburg position

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Postoperative hospital stay (days)
Time Frame: Up to 4 weeks
Based on a discharge checklist
Up to 4 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Operation time
Time Frame: Up to 4 hours
minutes
Up to 4 hours
Blood-loss peroperative
Time Frame: During surgery time
ml
During surgery time
Diuretics peroperative and postoperative
Time Frame: Up to 4 weeks (during hospital stay)
mg
Up to 4 weeks (during hospital stay)
Postoperative hypoxemia
Time Frame: Up to 1 week
O2 saturation
Up to 1 week
Peri- and postoperative surgical complications
Time Frame: Up to 4 weeks
number
Up to 4 weeks
Pulmonary complications.
Time Frame: Up to 4 weeks
number
Up to 4 weeks
Cardiac complications
Time Frame: Up to 4 weeks
number
Up to 4 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Anke B Smits, MD, St. Antonius Hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 1, 2015

Primary Completion (Anticipated)

June 1, 2020

Study Completion (Anticipated)

October 1, 2020

Study Registration Dates

First Submitted

May 4, 2017

First Submitted That Met QC Criteria

November 2, 2017

First Posted (Actual)

November 7, 2017

Study Record Updates

Last Update Posted (Actual)

May 31, 2019

Last Update Submitted That Met QC Criteria

May 29, 2019

Last Verified

May 1, 2019

More Information

Terms related to this study

Other Study ID Numbers

  • 49877 (Registry Identifier: CCMO (toetsingonline.nl): ABR form)

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Colon Carcinoma

Clinical Trials on Sponge

3
Subscribe